Back

Differential prognostic impact of blood glucose levels at the acute stage of myocardial infarction according to HbA1c. The FAST-MI programme

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 5 - Biomarkers lipid glucose Epidemiology, Prognosis, Outcome ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Nicolas Danchin

Saint Joseph Hospital, Paris (France)

4 More presentations in this session

Presentation thumbnail
Prognostic interest of HbA1c and plasma glucose assessment on one-year mortality in non-diabetic patients after acute myocardial infarction
Doctor E. Ratheau (Dijon, FR)
Abstract Slides
Presentation thumbnail
PFA-100, a test of platelet adhesion/aggregation, predicts cardiovascular events after an acute coronary syndrome and can help in the decision-making for dual antiplatelet extension
Doctor S. Chiappino (Massa, IT)
Abstract Slides
Presentation thumbnail
Lipoprotein(a) is not associated with survival after acute coronary syndromes
Doctor C. Roth (Vienna, AT)
Abstract
Presentation thumbnail
In patients with acute myocardial infarction, PCSK9 levels do not predict severity and recurrence of cardiovascular events
Professor M. Zeller (Dijon, FR)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 5 - Biomarkers lipid glucose

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources